U-M researchers: Canker sore drug could be used for weight loss
Editor's note: The photo credit has been corrected.
The next weight-loss drug could be one already familiar to those with asthma and canker sores, according to researchers at the University of Michigan.
Obese mice treated with the drug Amlexanox lost weight and reversed metabolic problems such as diabetes and fatty livers.
Courtesy of the U-M Life Sciences Institute
Dr. Elif Oral, associate professor of internal medicine and medical director of U-M Health System's Bariatric Surgery Program, is seeking individuals who are obese or have Type 2 diabetes for a new study to test the drug's effects on humans.
Individuals can be on oral diabetes medication and should have a body mass index between 27 and 36. Only 10 people are needed for this stage of the clinical trial.